FDA Panel Backs Implant for Mild Heart Failure

COLLEGE PARK, Md. (AP) - Federal health advisers say an
electronic heart implant should be approved for millions of new
heart-disease patients who currently aren't eligible for the

A Food and Drug Administration panel of cardiologists voted
unanimously in favor of Boston Scientific's heart-regulating device
to treat mild heart failure. Currently the device is approved for
moderate to severe heart failure.

The FDA is not required to follow the panel's advice, though it
often does.

A positive FDA decision would expand the market for the devices
by millions of patients.

The device combines a defibrillator, which shocks the heart to
correct irregular beats, with a resynchronization device to
coordinate the pumping action of the heart.

(Copyright 2010 by The Associated Press. All Rights Reserved.)

WTVY-TV 285 N Foster Street Dothan, AL 36303 334-792-3195
Copyright © 2002-2016 - Designed by Gray Digital Media - Powered by Clickability 88505427 - wtvy.com/a?a=88505427
Gray Television, Inc.